Previous Close | 30.69 |
Open | 30.99 |
Bid | 30.10 x 36100 |
Ask | 33.84 x 41800 |
Day's Range | 30.99 - 30.99 |
52 Week Range | 17.45 - 46.05 |
Volume | |
Avg. Volume | 2,220 |
Market Cap | 2.446B |
Beta (5Y Monthly) | 1.53 |
PE Ratio (TTM) | 23.48 |
EPS (TTM) | 1.32 |
Earnings Date | Nov 15, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Bavarian Nordic (BVNRY) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Bavarian Nordic has already said it would prioritise mpox vaccine production to fulfil orders this year.